Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Clinical Trials Using Iodinated Contrast Agent

Review the clinical trials studying iodinated contrast agent on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 1-13 of 13

Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) with the Contrast Agent Iohexol
Status: Active
Location: 161 locations
Atezolizumab in Combination with Chemotherapy in Treating Pediatric Patients with Relapsed or Refractory Solid Tumors, VITAS Trial
Status: Active
Location: 7 locations
Cardiac Imaging Stress Tests to Evaluate Cardiac Outcomes in Stage I-III Breast Cancer Patients Receiving Near Complete Estrogen Deprivation Therapy, CROWN Study
Status: Active
Location: 3 locations
Avutometinib for the Treatment of Pediatric Patients with Refractory or Recurrent Solid Tumors Harboring Activating MAPK Pathway Alterations
Status: Active
Location: 2 locations
Autologous B7-H3 Chimeric Antigen Receptor T Cells (B7-H3CART) for the Treatment of Children and Young Adults with Relapse or Refractory Neuroblastoma, Soft Tissue Sarcoma, Osteosarcoma, Ewing Sarcoma, and Wilms Tumor
Status: Active
Location: 2 locations
TGFbeta-imprinted Natural Killer Cells in Combination with Irinotecan, Temozolomide, and Dinutuximab for the Treatment of Patients with Relapsed or Refractory Neuroblastoma, Allo-STING Trial
Status: Active
Location: Nationwide Children's Hospital, Columbus, Ohio
AB821 for the Treatment of Unresectable or Metastatic Melanoma or other Recurrent, Locally Advanced, or Metastatic Solid Tumors
Status: Active
Location: Yale University, New Haven, Connecticut
Rectus Sheath Block with Liposomal Bupivacaine versus Thoracic Epidural Analgesia for Pain Control following Pancreatoduodenectomy
Status: Active
Location: University of Minnesota/Masonic Cancer Center, Minneapolis, Minnesota
Contrast-Enhanced Mammography for the Improvement of Surveillance in Women with a Personal History of Breast Cancer
Status: Active
Location: 3 locations
Contrast Enhanced Ultrasound Medical Imaging for Identifying Breast Masses
Status: Active
Location: 2 locations
Advanced Imaging Methods to Distinguish True Progression from Pseudoprogression in Patients with Brain Cancer
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
Contrast Enhanced Spectral Mammography for the Evaluation of Pathologic Nipple Discharge
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
Comparison of Contrast Enhanced Digital Breast Tomosynthesis and Magnetic Resonance Imaging in Patients with Known Breast Lesions
Status: Active
Location: UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina